Jim Shannon – 2015 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Jim Shannon on 2015-11-03.

To ask the Secretary of State for Health, what representations he has made to manufacturers on minimising increases in the price of insulin for treating type 1 diabetes.

George Freeman

There have been no such representations or discussions. The prices of branded medicines are controlled by the 2014 Pharmaceutical Price Regulation Scheme or under the statutory scheme established under the Health Service Branded Medicines (Control of Prices and Supply of Information) (No.2) Regulations 2008 and the Health Service Medicines (Information Relating to Sales of Branded Medicines etc.) Regulations 2007.